EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Bcl-2 protects mice against fatal alphavirus encephalitis






Proceedings of the National Academy of Sciences of the United States of America 93(10): 4810-4815

Bcl-2 protects mice against fatal alphavirus encephalitis

Virus-induced apoptosis has been well characterized in vitro, but the role of apoptosis in viral pathogenesis is not well understood. The suicide of a cell in response to viral infection is postulated to be an important host defense for the organism, leading to a reduction in its total viral burden. However, virus-induced death of nonregenerating cells in the central nervous system may be detrimental to the host. Therefore, to investigate the role of apoptosis in the pathogenesis of fatal encephalitis, we constructed a recombinant alphavirus chimera that expresses the antiapoptotic gene, bcl-2, in virally infected neural cells. Infection of neonatal mice with the alphavirus chimera expressing human bcl-2 [Sindbis virus (SIN)/bcl-2] resulted in a significantly lower mortality rate (7.5%) as compared with infection with control chimeric viruses containing a chloramphenicol acetyltransferase (CAT) reporter gene (SIN/CAT) (78.1%) or bcl-2 containing a premature stop codon (SIN/bcl-2stop) (72.1%) (P < 0.001). Viral titers were reduced 5-fold 1 day after infection and 10-fold 6 days after infection in the brains of SIN/bcl-2-infected mice as compared to SIN/CAT or SIN/bcl-2stop-infected mice. In situ end labeling to detect apoptotic nuclei demonstrated a reduction in the number of foci of apoptotic cells in the brains of mice infected with SIN/bcl-2 as compared with SIN/bcl-2stop. The reduction in apoptosis was associated with a reduction in the number of foci of cells expressing alphavirus RNA. Thus, the antiapoptotic gene, bcl-2, suppresses viral replication and protects against a lethal viral disease, suggesting an interaction between cellular genetic control of viral replication and cell death.

Accession: 002763187

PMID: 8643485

DOI: 10.2307/38858

Download PDF Full Text: Bcl-2 protects mice against fatal alphavirus encephalitis



Related references

Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. Journal of Neuropathology and Experimental Neurology 66(6): 533-544, 2007

Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice. Journal of Neuroinflammation 13(1): 196-196, 2016

Age-dependent susceptibility to fatal encephalitis: alphavirus infection of neurons. Archives of Virology. Supplementum 9: 31-39, 1994

Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. Journal of Immunology 152(3): 1289-1297, 1994

Antibody and interleukin-12 treatment in murine models of encephalitogenic flavivirus (St. Louis encephalitis, tick-borne encephalitis) and alphavirus (Venezuelan equine encephalitis) infection. Journal of Interferon & Cytokine Research 23(1): 47-50, 2003

Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice. Asn Neuro 4(4): 207-221, 2012

Immune responses to acute alphavirus infection of the central nervous system: Sindbis virus encephalitis in mice. Progress in Brain Research 59: 11-21, 1983

Protection of mice against aerosol challenge with Venezuelan equine encephalitis virus by alphavirus specific monoclonal antibodies. FASEB Journal 10(6): A1082, 1996

Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus. Vaccine 27(32): 4309-4319, 2009

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. Plos Neglected Tropical Diseases 4(6): E725-E725, 2010